<VariationArchive VariationID="1069134" VariationName="NM_014140.4(SMARCAL1):c.1263dup (p.Glu422fs)" VariationType="Duplication" Accession="VCV001069134" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-19" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1059174" VariationID="1069134">
      <GeneList>
        <Gene Symbol="SMARCAL1" FullName="SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" GeneID="50485" HGNC_ID="HGNC:11102" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q35</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="216412484" stop="216483053" display_start="216412484" display_stop="216483053" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="217277136" stop="217347775" display_start="217277136" display_stop="217347775" Strand="+" />
          </Location>
          <OMIM>606622</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014140.4(SMARCAL1):c.1263dup (p.Glu422fs)</Name>
      <CanonicalSPDI>NC_000002.12:216428710:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q35</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="216428710" stop="216428711" display_start="216428710" display_stop="216428711" variantLength="1" positionVCF="216428710" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="217293433" stop="217293434" display_start="217293433" display_stop="217293434" variantLength="1" positionVCF="217293433" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>E422fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.217293434dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.217293434dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.216428711dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.216428711dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009771.1" sequenceAccession="NG_009771" sequenceVersion="1" change="g.21298dup">
            <Expression>NG_009771.1:g.21298dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127207.2" sequenceAccession="NM_001127207" sequenceVersion="2" change="c.1263dup">
            <Expression>NM_001127207.2:c.1263dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120679.1" sequenceAccession="NP_001120679" sequenceVersion="1" change="p.Glu422fs">
            <Expression>NP_001120679.1:p.Glu422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014140.4" sequenceAccession="NM_014140" sequenceVersion="4" change="c.1263dup" MANESelect="true">
            <Expression>NM_014140.4:c.1263dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054859.2" sequenceAccession="NP_054859" sequenceVersion="2" change="p.Glu422fs">
            <Expression>NP_054859.2:p.Glu422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_108" sequenceAccession="LRG_108">
            <Expression>LRG_108:g.21298dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2106029249" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014140.4(SMARCAL1):c.1263dup (p.Glu422fs) AND Schimke immuno-osseous dysplasia" Accession="RCV001380885" Version="4">
        <ClassifiedConditionList TraitSetID="1147">
          <ClassifiedCondition DB="MedGen" ID="C0877024">Schimke immuno-osseous dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11799392</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301550</ID>
          <ID Source="BookShelf">NBK1376</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1147" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5333" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Schimke immuno-osseous dysplasia</ElementValue>
                <XRef ID="MONDO:0009458" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Schimke immunoosseous dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spondyloepiphyseal dysplasia nephrotic syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SIOD</ElementValue>
                <XRef Type="MIM" ID="242900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4984" />
                <XRef ID="4984" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Schimke immunoosseous dysplasia (SIOD) is characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small ilia with shallow dysplastic acetabular fossae, and small deformed capital femoral epiphyses. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease. The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with a greater risk of death during childhood to a juvenile or milder later-onset form with likely survival into adulthood if renal disease is appropriately treated.</Attribute>
                <XRef ID="NBK1376" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301550</ID>
                <ID Source="BookShelf">NBK1376</ID>
              </Citation>
              <XRef ID="1830" DB="Orphanet" />
              <XRef ID="C0877024" DB="MedGen" />
              <XRef ID="MONDO:0009458" DB="MONDO" />
              <XRef Type="MIM" ID="242900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3104673" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11802749|MedGen:C0877024" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579070" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11799392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301550</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SMARCAL1 are known to be pathogenic (PMID: 11799392, 20301550). This variant has not been reported in the literature in individuals with SMARCAL1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu422Argfs*6) in the SMARCAL1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCAL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.217293433_217293434insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0877024" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3104673" TraitType="Disease" MappingType="XRef" MappingValue="C0877024" MappingRef="MedGen">
        <MedGen CUI="C0877024" Name="Schimke immuno-osseous dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

